Literature DB >> 7632896

Nerve growth factor in Alzheimer's disease: defective retrograde transport to nucleus basalis.

E J Mufson1, J M Conner, J H Kordower.   

Abstract

NGF immunohistochemistry was combined with quantitative optical densitometry to evaluate whether retrogradely transported NGF is altered within cholinergic basal forebrain (CBF) neurons in Alzheimer's disease (AD). In normal aged humans, almost all CBF neurons stained for NGF. Although fewer in total number, remaining CBF perikarya in AD displayed diminished (32%) or undetectable NGF immunoreactivity. Based upon these data we hypothesize that there is a defect in retrograde transport of NGF in AD which may be due to a abnormal production and/or utilization of the trk receptor. This defect may be a primary event mediating the degeneration of CBF neurons in AD.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7632896     DOI: 10.1097/00001756-199505090-00028

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  43 in total

1.  Nontropic actions of neurotrophins: subcortical nerve growth factor gene delivery reverses age-related degeneration of primate cortical cholinergic innervation.

Authors:  J M Conner; M A Darracq; J Roberts; M H Tuszynski
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

Review 2.  On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer's disease.

Authors:  Simona Capsoni; Antonino Cattaneo
Journal:  Cell Mol Neurobiol       Date:  2006-08-31       Impact factor: 5.046

3.  Age-dependent loss of NGF signaling in the rat basal forebrain is due to disrupted MAPK activation.

Authors:  Brice Williams; Ann-Charlotte Granholm; Kumar Sambamurti
Journal:  Neurosci Lett       Date:  2006-12-19       Impact factor: 3.046

4.  Disease duration and the integrity of the nigrostriatal system in Parkinson's disease.

Authors:  Jeffrey H Kordower; C Warren Olanow; Hemraj B Dodiya; Yaping Chu; Thomas G Beach; Charles H Adler; Glenda M Halliday; Raymond T Bartus
Journal:  Brain       Date:  2013-08       Impact factor: 13.501

5.  Pretangle pathology within cholinergic nucleus basalis neurons coincides with neurotrophic and neurotransmitter receptor gene dysregulation during the progression of Alzheimer's disease.

Authors:  Chelsea T Tiernan; Stephen D Ginsberg; Bin He; Sarah M Ward; Angela L Guillozet-Bongaarts; Nicholas M Kanaan; Elliott J Mufson; Scott E Counts
Journal:  Neurobiol Dis       Date:  2018-05-31       Impact factor: 5.996

6.  Postmortem Brain, Cerebrospinal Fluid, and Blood Neurotrophic Factor Levels in Alzheimer's Disease: A Systematic Review and Meta-Analysis.

Authors:  Yang Du; Huan-Tong Wu; Xiao-Yan Qin; Chang Cao; Yi Liu; Zong-Ze Cao; Yong Cheng
Journal:  J Mol Neurosci       Date:  2018-06-28       Impact factor: 3.444

7.  Identification of critical residues within the conserved and specificity patches of nerve growth factor leading to survival or differentiation.

Authors:  Sidharth Mahapatra; Hrishikesh Mehta; Sang B Woo; Kenneth E Neet
Journal:  J Biol Chem       Date:  2009-09-17       Impact factor: 5.157

8.  Differential cortical neurotrophin and cytogenetic adaptation after voluntary exercise in normal and amnestic rats.

Authors:  J M Hall; R P Vetreno; L M Savage
Journal:  Neuroscience       Date:  2013-11-09       Impact factor: 3.590

9.  Diminished trkA receptor signaling reveals cholinergic-attentional vulnerability of aging.

Authors:  Vinay Parikh; William M Howe; Ryan M Welchko; Sean X Naughton; Drew E D'Amore; Daniel H Han; Monika Deo; David L Turner; Martin Sarter
Journal:  Eur J Neurosci       Date:  2012-12-11       Impact factor: 3.386

Review 10.  Use of genetically modified mesenchymal stem cells to treat neurodegenerative diseases.

Authors:  Robert D Wyse; Gary L Dunbar; Julien Rossignol
Journal:  Int J Mol Sci       Date:  2014-01-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.